KAS
BSX icon

Kestra Advisory Services’s Boston Scientific BSX Stock Holding History

Kestra Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15M Sell
167,463
-43,995
-21% -$2.39M 0.02% 659
2026
Q1 		$13.3M Buy
211,458
+5,321
+3% +$426K 0.05% 381
2025
Q4 		$19.7M Buy
206,137
+38,006
+23% +$3.73M 0.08% 247
2025
Q3 		$16.4M Buy
168,131
+3,168
+2% +$328K 0.08% 269
2025
Q2 		$17.7M Sell
164,963
-22,267
-12% -$2.25M 0.09% 230
2025
Q1 		$18.9M Sell
187,230
-29,366
-14% -$2.96M 0.09% 192
2024
Q4 		$19.3M Buy
216,596
+1,784
+0.8% +$157K 0.11% 190
2024
Q3 		$18M Sell
214,812
-30,912
-13% -$2.44M 0.1% 216
2024
Q2 		$18.9M Sell
245,724
-11,361
-4% -$832K 0.11% 205
2024
Q1 		$17.6M Buy
257,085
+4,377
+2% +$281K 0.12% 170
2023
Q4 		$14.6M Sell
252,708
-13,842
-5% -$739K 0.12% 186
2023
Q3 		$14.1M Buy
266,550
+142,567
+115% +$7.48M 0.14% 160
2023
Q2 		$6.71M Sell
123,983
-27,929
-18% -$1.46M 0.07% 298
2023
Q1 		$7.6M Sell
151,912
-12,341
-8% -$582K 0.08% 257
2022
Q4 		$7.6M Sell
164,253
-196,481
-54% -$8.51M 0.07% 312
2022
Q3 		$14M Buy
360,734
+190,874
+112% +$7.66M 0.15% 155
2022
Q2 		$6.33M Buy
169,860
+19,857
+13% +$808K 0.07% 305
2022
Q1 		$6.64M Buy
150,003
+37,625
+33% +$1.63M 0.07% 304
2021
Q4 		$4.77M Sell
112,378
-1,751
-2% -$73.6K 0.05% 383
2021
Q3 		$4.95M Buy
114,129
+4,433
+4% +$196K 0.05% 392
2021
Q2 		$4.69M Buy
109,696
+5,751
+6% +$242K 0.05% 373
2021
Q1 		$4.02M Sell
103,945
-150,537
-59% -$5.7M 0.05% 382
2020
Q4 		$9.05M Buy
254,482
+146,911
+137% +$5.29M 0.1% 219
2020
Q3 		$4.2M Buy
+107,571
New +$4.15M 0.08% 266

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kestra Advisory Services's BSX Position: Q2 2026 in Review

Kestra Advisory Services reduced its Boston Scientific (BSX) stake by 21% in Q2 2026, selling an estimated $2.39M and leaving 167,463 shares worth $7.15M. The position accounts for 0.02% of the portfolio, ranked #659.

Kestra Advisory Services first reported a position in BSX in Q3 2020 and has held it in 24 quarters since. The position peaked at $19.7M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kestra Advisory Services held 167,463 shares of Boston Scientific worth $7.15M as of Q2 2026.
  • Kestra Advisory Services sold 43,995 Boston Scientific shares in Q2 2026, an estimated $2.39M.
  • Boston Scientific made up 0.02% of Kestra Advisory Services's portfolio in Q2 2026, its #659 holding.
  • Kestra Advisory Services first reported a position in Boston Scientific in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's Boston Scientific position peaked at $19.7M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.